Northwestern Medicine has launched a COVID Prevention Trials Registry for people who are interested in participating in COVID-19 clinical trials to prevent infection from the virus.
Northwestern Medicine has launched a COVID Prevention Trials Registry for people who are interested in participating in COVID-19 clinical trials to prevent infection from the virus.
The research is being sponsored by Northwestern University Feinberg School of Medicine.
“We want to recruit participants in the Chicago area who are at risk for exposure to COVID-19 and who are potentially interested in participating in different studies for prevention of the infection,” said Dr. Karen Krueger, the principle investigator of the registry. She is a Northwestern Medicine physician and instructor in infectious diseases at Feinberg School of Medicine.
Participants in the registry will be contacted when an appropriate study based on their health profile is being conducted. The goal is to recruit 5,000 individuals for the COVID Prevention Trials Registry.
Read more at Northwestern University
Photo Credit: ulleo via Pixabay
